Ura, B.; Capaci, V.; Aloisio, M.; Di Lorenzo, G.; Romano, F.; Ricci, G.; Monasta, L.
A Targeted Proteomics Approach for Screening Serum Biomarkers Observed in the Early Stage of Type I Endometrial Cancer. Biomedicines 2022, 10, 1857.
https://doi.org/10.3390/biomedicines10081857
AMA Style
Ura B, Capaci V, Aloisio M, Di Lorenzo G, Romano F, Ricci G, Monasta L.
A Targeted Proteomics Approach for Screening Serum Biomarkers Observed in the Early Stage of Type I Endometrial Cancer. Biomedicines. 2022; 10(8):1857.
https://doi.org/10.3390/biomedicines10081857
Chicago/Turabian Style
Ura, Blendi, Valeria Capaci, Michelangelo Aloisio, Giovanni Di Lorenzo, Federico Romano, Giuseppe Ricci, and Lorenzo Monasta.
2022. "A Targeted Proteomics Approach for Screening Serum Biomarkers Observed in the Early Stage of Type I Endometrial Cancer" Biomedicines 10, no. 8: 1857.
https://doi.org/10.3390/biomedicines10081857
APA Style
Ura, B., Capaci, V., Aloisio, M., Di Lorenzo, G., Romano, F., Ricci, G., & Monasta, L.
(2022). A Targeted Proteomics Approach for Screening Serum Biomarkers Observed in the Early Stage of Type I Endometrial Cancer. Biomedicines, 10(8), 1857.
https://doi.org/10.3390/biomedicines10081857